Putting Proteomics Into Immunotherapy for Glioblastoma
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.593255
Abstract: In glioblastoma, the most aggressive brain cancer, a complex microenvironment of heterogeneity and immunosuppression, are considerable hurdles to classify the subtypes and promote treatment progression. Treatments for glioblastoma are similar to standard therapies for many… read more here.
Keywords: proteomics immunotherapy; putting proteomics; immunotherapy glioblastoma; glioblastoma ... See more keywords
Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.812916
Abstract: Glioblastoma is the most aggressive brain tumor with a median survival ranging from 6.2 to 16.7 months. The complex interactions between the tumor and the cells of tumor microenvironment leads to tumor evolution which ultimately… read more here.
Keywords: tumor; glioblastoma; immunotherapy glioblastoma; tumor microenvironment ... See more keywords
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12030751
Abstract: Glioblastomas are aggressive, fast-growing primary brain tumors. After standard-of-care treatment with radiation in combination with temozolomide, the overall prognosis of newly diagnosed patients remains poor, with a 2-year survival rate of less than 20%. The… read more here.
Keywords: immunotherapy glioblastoma; glioblastoma current; future perspectives; shortcomings future ... See more keywords
Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12092334
Abstract: Glioblastoma is the most lethal intracranial primary malignancy by no optimal treatment option. Cancer immunotherapy has achieved remarkable survival benefits against various advanced tumors, such as melanoma and non-small-cell lung cancer, thus triggering great interest… read more here.
Keywords: immunotherapy glioblastoma; glioblastoma current; immunotherapy; glioblastoma ... See more keywords
Emerging Biomarkers for Immunotherapy in Glioblastoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14081940
Abstract: Simple Summary Immunotherapy has shown clinical benefits in several solid cancers; still, glioblastoma remains very challenging to treat. Glioblastoma is the most frequent brain cancer and displays great heterogeneity. The standard of care has remained… read more here.
Keywords: emerging biomarkers; immunotherapy; cancer; biomarkers immunotherapy ... See more keywords
Next Steps for Immunotherapy in Glioblastoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14164023
Abstract: Simple Summary Prognosis for glioblastoma patients remains poor despite the current standard of care treatments. More recent investigations have focused on immunotherapy, which utilizes a patient’s immune system to target cancer cells. Though proven to… read more here.
Keywords: efficacy; next steps; immunotherapy glioblastoma; steps immunotherapy ... See more keywords